Oxidative damage is a crucial factor in the development of MS and its associated complication that was further indicated in our study by a significant elevation in the hepatic MDA level with a significant decline in hepatic SOD, GSH, CAT, as well as sTAC concentrations, in the MS group. This evidence concerns the gene CAT and myeloid sarcoma.